Jones Financial Companies Lllp Acquires 1,228 Shares of Revvity, Inc. (NYSE:RVTY)

Jones Financial Companies Lllp raised its holdings in shares of Revvity, Inc. (NYSE:RVTY) by 39.8% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,312 shares of the company’s stock after purchasing an additional 1,228 shares during the period. Jones Financial Companies Lllp’s holdings in Revvity were worth $481,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the business. EdgePoint Investment Group Inc. increased its position in Revvity by 34.6% during the 3rd quarter. EdgePoint Investment Group Inc. now owns 2,685,775 shares of the company’s stock valued at $343,108,000 after buying an additional 690,534 shares in the last quarter. Southpoint Capital Advisors LP purchased a new stake in shares of Revvity in the third quarter worth $25,550,000. Proficio Capital Partners LLC increased its holdings in shares of Revvity by 12,298.3% during the fourth quarter. Proficio Capital Partners LLC now owns 195,769 shares of the company’s stock valued at $21,850,000 after acquiring an additional 194,190 shares in the last quarter. Janus Henderson Group PLC raised its position in shares of Revvity by 1.7% in the 3rd quarter. Janus Henderson Group PLC now owns 6,335,302 shares of the company’s stock worth $809,332,000 after purchasing an additional 108,401 shares during the last quarter. Finally, Holocene Advisors LP boosted its stake in Revvity by 14.6% in the 3rd quarter. Holocene Advisors LP now owns 725,917 shares of the company’s stock worth $92,736,000 after purchasing an additional 92,240 shares in the last quarter. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Revvity news, insider Tajinder S. Vohra sold 5,492 shares of the firm’s stock in a transaction that occurred on Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total transaction of $641,520.52. Following the completion of the transaction, the insider now owns 19,652 shares in the company, valued at $2,295,550.12. This trade represents a 21.84 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Joel S. Goldberg sold 15,170 shares of Revvity stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $126.73, for a total value of $1,922,494.10. Following the completion of the sale, the insider now directly owns 33,400 shares in the company, valued at approximately $4,232,782. The trade was a 31.23 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.60% of the company’s stock.

Revvity Stock Performance

RVTY opened at $118.40 on Tuesday. The company’s 50 day moving average is $117.05 and its 200 day moving average is $118.20. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41. The company has a market cap of $14.23 billion, a price-to-earnings ratio of 53.58, a PEG ratio of 3.82 and a beta of 1.06. Revvity, Inc. has a 12-month low of $97.32 and a 12-month high of $129.50.

Revvity (NYSE:RVTY) last issued its quarterly earnings results on Friday, January 31st. The company reported $1.42 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same quarter in the previous year, the firm posted $1.25 EPS. On average, equities research analysts predict that Revvity, Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be issued a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.24%. The ex-dividend date is Thursday, April 17th. Revvity’s dividend payout ratio is presently 12.67%.

Analyst Ratings Changes

RVTY has been the subject of a number of analyst reports. KeyCorp raised their price objective on shares of Revvity from $132.00 to $145.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. Barclays boosted their price objective on shares of Revvity from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Sanford C. Bernstein cut Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 price objective on the stock. in a research report on Friday, January 10th. Bank of America raised Revvity from a “neutral” rating to a “buy” rating and set a $138.00 target price for the company in a report on Friday, December 13th. Finally, Raymond James reaffirmed an “outperform” rating and set a $145.00 price target (up from $140.00) on shares of Revvity in a report on Monday, February 3rd. Four analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $136.25.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.